Feasibility of unmanipulated haploidentical stem cell transplantation using standard GVHD prophylaxis for HLA-homozygous patients

International Journal of Hematology, 06/08/2012

The findings may serve as a rationale for considering haploidentical hematopoietic stem cell transplantation (haplo–SCT) as a treatment option for HLA–homozygous patients.

Print Article Summary